25th Jan 2022 14:48
(Alliance News) - Mycelx Technologies Corp announced on Tuesday that it successfully completed a trial of its PFAS remediation system in the US.
Shares in Mycelx were up 18% at 81.93 pence on Tuesday afternoon in London.
The Georgia, US-based clean water and air technology company said the results of the trial confirm the ability of its PFAS remediation system to reduce contamination to a non-detect level in a single pass through the system.
PFAS refers to perfluoroakyl and polyfluoroalkyl compounds which are a collection of long-lasting man-made toxic chemicals that present a threat to the environment and human health.
The trial involved treating PFAS contaminated water from a storm water retention pond and successfully demonstrated the ability of Mycelx's system to completely remove all detected chemicals to non-detectable concentrations in a single pass.
By Heather Rydings; [email protected]
Copyright 2022 Alliance News Limited. All Rights Reserved.
Related Shares:
Mycelx Di